Application of Techniques, Interpretation and Differential Diagnosis —
Training activity: 6

Details

Select and interpret the appropriate techniques for the investigation of:

• Thrombotic disorders

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

What are the intended outcomes of the training activity?

• How will you focus your attention on the requirement to select and interpret the most appropriate laboratory techniques specifically for investigating thrombotic disorders?
• In what ways will reviewing the specified learning outcomes help you contextualise the need for detailed practical knowledge and experience in screening investigations?
• How will you ensure you develop the ability to describe the limitations of the techniques applied during these clinical investigations?
• What steps will you take to ensure you can apply the principles of internal quality control (IQC) and external quality assessment (EQA) to draw robust conclusions about assay performance?
• How will this activity prepare you to demonstrate appropriate communication skills when presenting investigation results and cases clearly to your healthcare professional colleagues?
• How will you use this task to practice generating a differential diagnosis and identifying necessary downstream or reflex tests to aid disease classification?

What do you anticipate you will learn from the experience?

• What specific insights do you hope to gain regarding the assays and methodologies used to investigate different aspects of the thrombotic process, such as hypercoagulability markers?
• How do you anticipate this experience will improve your ability to interpret results in the context of various thrombotic risk factors and clinical events?
• What do you expect to learn about the role of laboratory testing in the overall diagnosis and management of patients with thrombotic disorders?
• How will this activity build upon your existing knowledge of thrombosis and its laboratory investigation to expand your practical understanding?
• In what ways do you anticipate this experience will prepare you for the interpretive and analytical responsibilities required for post-programme professional practice?

What actions will you take in preparation for the experience?

• How will you discuss with your training officer which specific thrombophilia tests and investigations you will be involved in selecting and interpreting?
• Which theoretical principles and laboratory procedures for thrombotic disorder investigations will you review to ensure your analytical accuracy?
• How will you prepare for potential challenges, such as interpreting complex panels of results or understanding the clinical significance of borderline findings?
• What resources, such as clinical guidelines or previous case studies, will you identify beforehand to support your ability to reach a valid interpretation?
• How do you feel about embarking on this task, and what specific areas have you identified for focused preparation to increase your confidence?

In action

What are you doing?

• As you select the specific assays for investigating thrombotic risk (such as tests for hypercoagulability), what is your rationale for choosing these particular methods based on the patient’s clinical presentation?
• What features of the data or markers of thrombotic risk are you focusing on first, and what decisions are you making as you begin to interpret the results?
• Which aspects of your diagnostic approach feel intuitive, and which parts—such as identifying the limitations of the techniques or correlating borderline results with clinical events—require more conscious effort and reference to guidelines?
• How are you approaching the investigation to ensure you are meeting the module’s aim of providing detailed practical knowledge and experience in screening investigations?

How are you progressing with the activity?

• How effective is your current selection of techniques in providing the necessary data to generate a differential diagnosis?
• What technical challenges or ambiguities are you facing during the activity (e.g., instrument operation issues, sample processing variables, or conflicting markers)?
• In what ways are you applying the principles of internal quality control (IQC) and external quality assessment (EQA) in the moment to conclude that the assay performance is robust?
• How does this investigation connect to your existing knowledge of the mechanisms of thrombosis and the pathophysiology of thrombotic disorders?
• What are you learning about the practical limitations of these specific investigations as the results unfold?

How are you adapting to the situation?

• Based on your initial interpretation, are there alternative approaches or reflex tests you should now consider to aid in disease classification or to clarify the thrombotic risk?
• How are you adapting your communication style in real-time to ensure that your presentation of these findings will be clear and actionable for a healthcare professional colleague?
• What support or guidance (such as specialist clinical guidelines, SOPs, or consultation with a supervisor) do you find yourself needing to resolve uncertainties in the results?
• Are you confident that you are working within your scope of practice and adhering to the laboratory’s established diagnostic protocols for thrombophilia testing?

On action

What did you notice?

• How would you summarise the key steps you took to select the most appropriate investigations for a patient presenting with a suspected thrombotic disorder?
• What specific features or data patterns—such as those found in hypercoagulability screens—did you focus on while interpreting the results?
• How did you evaluate the internal quality control (IQC) and external quality assessment (EQA) data to conclude that the assay performance was reliable before you finalised your interpretation?
• What did you notice about your communication of the findings? Were you able to present the results and potential differential diagnosis clearly to your healthcare professional colleagues?
• Were there any unexpected challenges or successes during the task, such as identifying a rare thrombotic marker or navigating the technical limitations of an assay?

What did you learn from the activity?

• What new skills or knowledge did you develop regarding the diagnostic pathways used to investigate thrombotic risk and events?
• How has this experience improved your ability to describe the limitations of the techniques you applied, and how did this influence your final interpretation?
• In what ways did your reflection-in-action (the decisions you made while the task was unfolding) influence the way you generated a differential diagnosis or identified reflex tests?
• What did you learn from correlating the laboratory data with the patient’s clinical history to reach a cohesive conclusion?
• How does this specific experience relate to the high-level interpretive requirements for your future role as a Clinical Scientist in post-programme practice?

What will you take from the experience moving forward?

• What areas for continued development have you identified in your ability to select appropriate investigations or to communicate complex thrombophilia results to a multidisciplinary team?
• How will you apply the learning from this activity to your routine laboratory practice, especially when faced with conflicting results or complex clinical presentations?
• What specific ‘next steps’ will you now take, such as reviewing the latest clinical guidelines for thrombosis or studying more case-based data, to support the assimilation of what you have learned?
• What support or resources, such as mentoring from senior clinical staff or access to specialist reference material, would further develop your expertise in this field?

Beyond action

Have you revisited the experiences?

• How has your understanding of the interplay between various assays—such as lupus anticoagulant testing or Factor V Leiden mutation analysis—and clinical presentations deepened as you evaluate and re-evaluate your previous engagement with this task?
• When comparing your reflections on this activity with those from other DTAs focusing on coagulation or inherited bleeding disorders, what specific similarities or differences in the investigative approaches have you noted over time?
• As part of your holistic review of the module, have any aspects of the interpretation of results for thrombotic risk become clearer or more nuanced as you have gained greater exposure to different case scenarios?
• How has engaging in professional storytelling with peers or senior colleagues regarding challenging thrombotic cases changed your perspective on alternative interpretations or diagnostic strategies?

How have these experiences impacted upon your current practice?

• How does your learning from this activity contribute to your broader understanding of haemostasis and thrombosis, rather than being seen as an isolated incident?
• In what ways has your proficiency in selecting techniques for thrombotic investigations influenced your ability to provide a rationale for specific downstream or reflex tests in your current daily practice?
• How have you applied your knowledge of internal quality control (IQC) and external quality assessment (EQA) since the original experience to ensure that your current conclusions about assay performance are robust?
• How has this experience directly supported your preparation for observed assessments, such as Case-Based Discussions (CBDs) or Direct Observations of Practical Skills (DOPS) related to coagulation and thrombotic risk assessments?
• Can you identify instances where your communication skills have improved when presenting complex thrombophilia results to healthcare professional colleagues?

How might these experiences contribute towards your future practice?

• Which transferable skills developed through this activity—such as the critical evaluation of complex test panels and the integration of clinical history with laboratory findings—will be most valuable in your future role as a Clinical Scientist?
• How will your ability to describe the limitations of the techniques used in thrombotic investigations help you ensure patient safety and provide better diagnostic advice in the future?
• What clear actions for continued development have you identified, such as staying updated with the latest clinical guidelines for hypercoagulability or mastering the classification of rare thrombotic disorders?
• How will the building blocks of learning from this activity help you navigate the high-level interpretive and analytical responsibilities of post-programme professional practice?

Relevant learning outcomes

#	Outcome
# 1	Outcome Select techniques for the investigation of clinical presentations in haematology, haemostasis and transfusion science and medicine.
# 3	Outcome Interpret the results of the laboratory investigations for cases including red and white cell disorders and haemostatic and platelet disorders, haematological malignancy and transfusion serology.
# 4	Outcome Describe the limitations of techniques applied in the investigation of clinical presentations in haematology, haemostasis and transfusion science.
# 5	Outcome Apply the principles of internal quality control and external quality assessment and draw conclusions about assay performance.
# 6	Outcome Demonstrate appropriate communication skills to present the results of investigations and cases clearly to healthcare professional colleagues.